New embryo test may boost IVF success without risky biopsies

NCT ID NCT04339166

Completed Knowledge-focused Sponsor: Peking University Third Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether testing the fluid around embryos (non-invasive chromosome screening, or NICS) can help doctors choose the best embryo for IVF. Over 1,100 couples took part, with women aged 35-42. The goal was to see if adding NICS to standard visual checks leads to more live births and fewer miscarriages compared to visual checks alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHROMOSOME ABNORMALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chromosomal disorder Chromosome Aberrations infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHROMOSOME ABNORMALITY INFERTILITY

Contacts and locations

Locations

Hebei Maternity and Reproductive hospital

Shijiazhuang, Hebei, China
Jinling Hospital,Nanjing University,School Medicine

Nanjing, Jiangsu, China
Northwest women's and children's hospital

Xi'an, China
Peking University Shenzhen Hospital

Shenzhen, Guangdong, China
Peking University Third Hospital

Beijing, China
Reproductive & Genetic Hospital of Citic-Xiangya

Changsha, Hunan, China
Shengjing Hospital of China Medical University

Shenyang, Liaoning, China
The First Affiliated Hospital,Sun Yat-sen University

Guanzhou, Guangdong, China
The First Medical Center of Chinese People's Liberation Army General Hospital

Beijing, China
The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China
The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China
The Third Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China
West China Second Hospital of Sichuan University

Chengdu, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.